検索結果 - Gail J. Roboz

結果の絞り込み
  1. 1
    Novel Approaches to the Treatment of Acute Myeloid Leukemia

    Novel Approaches to the Treatment of Acute Myeloid Leukemia 著者: Gail J. Roboz

    出版事項 2011
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  2. 2
    Acute myeloid leukemia stem cells: seek and destroy

    Acute myeloid leukemia stem cells: seek and destroy 著者: Gail J. Roboz, Mónica L. Guzmán

    出版事項 2009
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  3. 3
    Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis

    Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis 著者: Gail J. Roboz, Sérgio Dias, George Lam, William J. Lane, Steven L. Soignet, Raymond P. Warrell, Shahin Rafii

    出版事項 2000
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  4. 4
    The BiTE (bispecific T‐cell engager) platform: Development and future potential of a targeted immuno‐oncology therapy across tumor types

    The BiTE (bispecific T‐cell engager) platform: Development and future potential of a targeted immuno‐oncology therapy across tumor types 著者: Hermann Einsele, Hossein Borghaei, Robert Z. Orlowski, Marion Subklewe, Gail J. Roboz, Gerhard Zugmaier, Peter Kufer, Karim Iskander, Hagop M. Kantarjian

    出版事項 2020
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  5. 5
    Prevalence, Management, and Clinical Consequences of QT Interval Prolongation During Treatment With Arsenic Trioxide

    Prevalence, Management, and Clinical Consequences of QT Interval Prolongation During Treatment With Arsenic Trioxide 著者: Gail J. Roboz, Ellen K. Ritchie, Rebecca F. Carlin, Michael S. Samuel, Leanne Gale, Juliette L. Provenzano-Gober, Tania J. Curcio, Eric J. Feldman, Paul Kligfield

    出版事項 2014
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  6. 6
    Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia

    Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia 著者: Ellen K. Ritchie, Eric J. Feldman, Paul J. Christos, Sarah D. Rohan, Catherine B. Lagassa, Cindy Ippoliti, Joseph M. Scandura, Karen-Sue Carlson, Gail J. Roboz

    出版事項 2012
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  7. 7
    The effect of initial molecular profile on response to recombinant interferon‐α (rIFNα) treatment in early myelofibrosis

    The effect of initial molecular profile on response to recombinant interferon‐α (rIFNα) treatment in early myelofibrosis 著者: Richard T. Silver, Ariella Barel, Elena Lascu, Ellen K. Ritchie, Gail J. Roboz, Paul J. Christos, Attilio Orazi, Duane C. Hassane, Wayne Tam, Nicholas C.P. Cross

    出版事項 2017
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  8. 8
    TP53 Mutations Predict Poorer Responses to CPX-351 in Acute Myeloid Leukemia

    TP53 Mutations Predict Poorer Responses to CPX-351 in Acute Myeloid Leukemia 著者: Aaron D. Goldberg, Chetasi Talati, Pinkal Desai, Christopher Famulare, Sean M. Devlin, Noushin Farnoud, David A. Sallman, Jeffrey E. Lancet, Gail J. Roboz, Kendra Sweet, Martin S. Tallman

    出版事項 2018
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  9. 9
    A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response

    A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response 著者: Keith W. Pratz, Jorge E. Cortés, Gail J. Roboz, Niranjan Rao, Omotayo Arowojolu, Adam Stine, Yukimasa Shiotsu, Aiko Shudo, Shiro Akinaga, Donald Small, Judith E. Karp, Mark J. Levis

    出版事項 2008
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  10. 10
    In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche

    In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche 著者: Hong Zong, Siddhartha Sen, Guodong Zhang, Mu Chuanjie, Z F Albayati, David G. Gorenstein, Yang Liu, M. Ferrari, Peter A. Crooks, Gail J. Roboz, Haifa Shen, Mónica L. Guzmán

    出版事項 2015
    全文の入手
    Carta
    お気に入りに追加
    保存先:
  11. 11
    FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels

    FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels 著者: Vicenta Trujillo-Alonso, Edwin C. Pratt, Hongliang Zong, Andres Lara-Martinez, Charalambos Kaittanis, Mohamed O. Rabie, Valerie A. Longo, Michael W. Becker, Gail J. Roboz, Jan Grimm, Mónica L. Guzmán

    出版事項 2019
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  12. 12
    A Chemical Biology Approach to the Chaperome in Cancer—HSP90 and Beyond

    A Chemical Biology Approach to the Chaperome in Cancer—HSP90 and Beyond 著者: Tony Taldone, Tai Wang, Anna Rodina, Nagavarakishore Pillarsetty, Chander Singh Digwal, Sahil Sharma, Pengrong Yan, Suhasini Joshi, Piyusha P. Pagare, Alexander Bolaender, Gail J. Roboz, Mónica L. Guzmán, Gabriela Chiosis

    出版事項 2019
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  13. 13
    Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations

    Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations 著者: Nuria Mencia-Trinchant, Yang Hu, Maria Antonina Alas, Fatima Bhopalwala Ali, Bas J. Wouters, Sang Min Lee, Ellen K. Ritchie, Pinkal Desai, Mónica L. Guzmán, Gail J. Roboz, Duane C. Hassane

    出版事項 2017
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  14. 14
    Somatic mutations precede acute myeloid leukemia years before diagnosis

    Somatic mutations precede acute myeloid leukemia years before diagnosis 著者: Pinkal Desai, Nuria Mencia-Trinchant, Oleksandr Savenkov, Michael S. Simon, Gloria Cheang, Sang‐Min Lee, Michael Samuel, Ellen K. Ritchie, Mónica L. Guzmán, Karla V. Ballman, Gail J. Roboz, Duane C. Hassane

    出版事項 2018
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  15. 15
    First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

    First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leuk... 著者: Eric J. Feldman, Jeffrey E. Lancet, Jonathan E. Kolitz, Ellen K. Ritchie, Gail J. Roboz, Alan F. List, Steven L. Allen, Ekatherine Asatiani, Lawrence D. Mayer, Christine E. Swenson, Arthur C. Louie

    出版事項 2011
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  16. 16
    Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (m <i>IDH1</i> ) acute myeloid leukemia (AML)

    Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (m <i>IDH1</i> ) acute myeloid leukemia (AML) 著者: Jorge E. Cortés, Brian A. Jonas, Gary J. Schiller, Alice S. Mims, Gail J. Roboz, Andrew H. Wei, Pau Montesinos, P. Brent Ferrell, Karen Yee, Pierre Fenaux, Anthony P. Schwarer, Justin M. Watts

    出版事項 2024
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  17. 17
    Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML

    Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML 著者: Joseph M. Scandura, Gail J. Roboz, Michelle Moh, Ewelina Morawa, Fabienne Brenet, Jahar R Bose, Luis Juárez Villegas, Usama Gergis, Sebastian Mayer, Cindy Ippoliti, Tania J. Curcio, Ellen K. Ritchie, Eric J. Feldman

    出版事項 2011
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  18. 18
    Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia

    Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia 著者: Gail J. Roboz, Ellen K. Ritchie, Yulia Dault, Linda Lam, Danielle C. Marshall, Nicole M. Cruz, Hsiao-Ting Hsu, Duane C. Hassane, Paul J. Christos, Cindy Ippoliti, Joseph M. Scandura, Mónica L. Guzmán

    出版事項 2018
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  19. 19
    Selective Activity of the Histone Deacetylase Inhibitor AR-42 against Leukemia Stem Cells: A Novel Potential Strategy in Acute Myelogenous Leukemia

    Selective Activity of the Histone Deacetylase Inhibitor AR-42 against Leukemia Stem Cells: A Novel Potential Strategy in Acute Myelogenous Leukemia 著者: Mónica L. Guzmán, Neng Yang, Krishan K. Sharma, Marlene Balys, Cheryl A. Corbett, Craig T. Jordan, Michael W. Becker, Ulrich Steidl, Omar Abdel‐Wahab, Ross L. Levine, Guido Marcucci, Gail J. Roboz, Duane C. Hassane

    出版事項 2014
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  20. 20
    Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia

    Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia 著者: Mayumi Sugita, Román Galetto, Hongliang Zong, Nathan Ewing-Crystal, Vicenta Trujillo-Alonso, Nuria Mencia-Trinchant, Winnie Yip, Stéphanie Filipe, Céline Lebuhotel, Agnès Gouble, Duane C. Hassane, Julianne Smith, Gail J. Roboz, Mónica L. Guzmán

    出版事項 2022
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: